Uncovering the Cancer Proteome with Automated Western Assays
A robust, automated western blot system accelerates immunotherapy development.
Identifying new protein targets within the tumor microenvironment improves cancer therapy efficacy. To do this, researchers typically employ tedious western blotting methods to characterize new cancer antigens and immune cell proteins. With next-generation protein analytical tools, scientists can obtain quantitative and reproducible protein expression data from as little as 3 microliters of sample in a matter of hours.
Download this application note from Bio-Techne to learn how researchers use automated western assay systems to understand tumor microenvironment heterogeneity and to develop CAR T cell therapies.
